Wyss Institute’s CircaVent team awarded grant from BD2 to advance research into bipolar disorder and development of more effective drugs
Jessica Leff
The philanthropic $4.5 million grant will enable the team to screen new, re-purposed drug candidates and apply them to patient-derived brain organoids to delve deeply into the causes of bipolar disorder